Banks and tech stocks lead ASX declines on Trump tariffs. ResMed reports earnings beat. Star sinks to record low after ...

Shares to slip after Wall St fell following a new round of Trump tariff threats. Resmed beats in fourth quarter earnings.

The ASX has dived after Donald Trump handed down a raft of tariffs including 10 per cent levies on Australian goods in his ...

The ASX 200 has dived on Thursday after US Federal Reserve chair said signalled he was unlikely to hand down rate cuts in the ...

Welcome to the Trading Day blog for Thursday, July 31. The ASX 200 closed down 0.2 per cent to 8742.8 points on resources ...

These ASX-listed explorers in Queensland have been steadily gaining ground on their projects over the June quarter. ... Read ...

In light of stronger retail sales and better-than-expected inflation data, here are 7 ASX retail stocks that brokers ...

Technology, healthcare and the big four banks led the market sell-off on Friday as US President Donald Trump made two ...

It’s 31 July, marking the official close of the June quarterly reporting period under ASX Listing Rules. For healthcare ...

The Australian sharemarket closed in the red as shares fell across the region in response to the US president’s sweeping ...

The GenusPlus share price has doubled in 12 months. We explore what’s driving the growth and why brokers are still bullish.

The ASX 200 dropped 1.7 per cent, erasing $45 billion in value as fears for the global economy mount. See how the day unfolded on our live blog.